glp 1 cgm GLP‑1 weight loss you can actually see working Combining GLP-1s with CGM for

In a meta-analysis 6 of eight trials with 60080 patients (ELIXA, LEADER, SUSTAIN-6, EXSCEL, Harmony Outcomes, REWIND, PIONEER 6, and AMPLITUDE-O) , treatment with a GLP-1 receptor agonist led to a 14% relative risk reduction in three-point MACE (HR 086 [95% CI 080093]

You also dont want to flush out remaining electrolytes by adding a large amount of plain water to your daily routine

It acts as an antifoaming agent to break up trapped bubbles and relieve abdominal pressure

STEP UP: In adults with obesity, along with diet and exercise, Wegovy HD (semaglutide) injection 7.2 mg: Designed to deliver greater weight-loss results than the Wegovy you know 1 Mean change in body weight (%) from week 0 to week 72 1 Co-primary end point 1 : Percentage of patients achieving 5% weight loss at 72 weeks: 88.7% of patients with Wegovy vs 38.3% with placebo HD Treatment regimen estimand: This estimand is based on the intention-to-treat principle and was used as the primary analysis method *Co-primary end point: % change in body weight for Wegovy HD vs placebo

This dual mechanism is what separates tirzepatide from older GLP-1 medications like semaglutide , which only activate the GLP-1 receptor